Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication.

Jean-Jacques ParientiAnna L FournierLaurent CotteMarie-Paule SchneiderManuel EtienneGuillemette UnalPhilippe PerréJean-Jacques DutheilElodie Morilland-LecoqFabien ChaillotDavid R BangsbergAmandine Gagneux-BrunonThierry PrazuckMatthias CavassiniRenaud VerdonLaurent Hocqueloux

Published in: Open forum infectious diseases (2021)

These findings support the concept that dolutegravir in combination with 2 other active ARVs achieves greater virological suppression than older ARVs, including raltegravir, NNRTI, and bPI, among PWH with lower adherence.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
community dwelling
middle aged
physical activity
glycemic control
type diabetes
hepatitis c virus
cross sectional
adipose tissue
double blind
hiv testing
replacement therapy
nucleic acid